In addition to the heterogeneity of tumors mentioned in this chapter, the explanation for this surprising discrepancy in the interpretation of the impact of FKN (favorable vs. unfavorable) on the course of cancer may be that the pro-inflammatory, anti-apoptotic, and pro-angiogenic effects mediated by the FKN/CX3CR1 axis are in opposition to the impact of this signaling pathway on immune system functions. The gene discussed is CX3CR1; the disease is cancer.